Sign In
Buy RPRX
$53.57
+0.610 (+1.15%)
At Close: Jun 22, 2026
Royalty Pharma (RPRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
11:06am, Thursday, 02'nd May 2024
Royalty Pharma (RPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
08:15am, Friday, 19'th Apr 2024
NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2024 financial results on Thursday, May 9, 2024 before the U.S. fin
Royalty Pharma Declares Second Quarter 2024 Dividend
08:15am, Wednesday, 17'th Apr 2024
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2024 of $0.21 per Class A ordi
3 Pharma Stocks to Sell in April Before They Crash & Burn
02:10pm, Thursday, 11'th Apr 2024
There are some pharma stocks to sell in April. Holding these companies is too risky, especially as the industry faces increasing regulatory scrutiny and pricing pressures.
Billionaire Bargain Bin: 3 Stocks the Forbes 400 Loves (That You've Never Heard Of)
04:12pm, Tuesday, 09'th Apr 2024
The Forbes 400 is a list of America's 400 wealthiest people. Right now, to get on the coveted list, one's net worth has to be at least $2.9 billion.
April's Hidden Gems: 3 Overlooked Stocks to Freshen Up Your Portfolio
12:24pm, Tuesday, 09'th Apr 2024
Today we dive deeper than the headlines to uncover overlooked stocks. In the artificial intelligence (AI) market of 2024, tech giants dominated the first quarter.
The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio
01:57pm, Wednesday, 27'th Mar 2024
With the market trading near all-time highs, undervalued healthcare stocks offer a compelling opportunity. Fundamentally, the sector could benefit from a rotation in the innovation ecosystem.
Royalty Pharma to Present at TD Cowen's 44th Annual Health Care Conference
04:15pm, Wednesday, 28'th Feb 2024
NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at TD Cowen's 44th Annual Health Care Conference on March 5, 2
Royalty Pharma (RPRX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
04:31pm, Friday, 16'th Feb 2024
While the top- and bottom-line numbers for Royalty Pharma (RPRX) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics
Wall Street Thinks These 3 Stocks Are Hidden Gems That Could Soar 43% to 59% Over the Next 12 Months
05:50am, Friday, 16'th Feb 2024
SLB expects strong growth in 2024. Alibaba stock is dirt cheap, and the company plans major buybacks over the next few years.
Royalty Pharma PLC (RPRX) Q4 2023 Earnings Call Transcript
01:39pm, Thursday, 15'th Feb 2024
Royalty Pharma PLC (RPRX) Q4 2023 Earnings Call Transcript
Royalty Pharma Reports Q4 and Full Year 2023 Results
07:30am, Thursday, 15'th Feb 2024
NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the fourth quarter and full year of 2023 and introduced full year 2024 guidance for P
3 Biotech Stocks to Buy for the Next Bull Run: February 2024
09:10am, Thursday, 08'th Feb 2024
The technology applied in the field of medicine undoubtedly surprises more and more investors every day. As technology advances in the world, biotech companies are in charge of applying it to improve
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
04:15pm, Tuesday, 30'th Jan 2024
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its fourth quarter and full year 2023 financial results on Thursday, February 15, 2024
Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
04:15pm, Monday, 27'th Nov 2023
NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at the Evercore ISI 6th Annual HealthCONx Conferenc
